In this research, we observed that the knockdown of PDPN dramatically depressed the activation of ezrin in GC cells, which was shown to be a contributor to cancer progression (Kong et al., 2016; Qureshi‐Baig et al., 2020). This evidence concerns the gene PDPN and cancer.